Vivos Therapeutics Inc (NAS:VVOS)
$ 2.1 -0.07 (-3.23%) Market Cap: 6.78 Mil Enterprise Value: 6.27 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 59/100

Vivos Therapeutics Inc at Benzinga Global Small Cap Conference (Virtual) Transcript

Oct 27, 2021 / 04:15PM GMT
Release Date Price: $88.25 (-1.67%)
Spencer Israel
Benzinga - Moderator

I see our next speaker here in the chat, let's see if we can bring them on. Vivos Therapeutics is the company, VVOS is the ticker. Kirk Huntsman is the Co-Founder, Chairman, and the CEO, and there he is. How are we doing today, sir?

Kirk Huntsman
Vivos Therapeutics, Inc. - CEO, Chairman, Co-Founder

Good, Spencer. How are you?

Spencer Israel
Benzinga - Moderator

Doing fantastic, fantastic. Thank you for asking. Let me get your slides up here. I see them.

Kirk Huntsman
Vivos Therapeutics, Inc. - CEO, Chairman, Co-Founder

All right.

Spencer Israel
Benzinga - Moderator

There they are. And all right. Very excited here about Vivos, tell us all about it.

Kirk Huntsman
Vivos Therapeutics, Inc. - CEO, Chairman, Co-Founder

All right. Thank you very much. Great to be back at Benzinga and appreciate the opportunity.

So Vivos is a medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot